Arete Wealth Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-811
Closed -$246K 594
2023
Q2
$246K Sell
811
-1,079
-57% -$300K 0.02% 545
2023
Q1
$498K Buy
1,890
+601
+47% +$153K 0.04% 344
2022
Q4
$309K Buy
1,289
+25
+2% +$5.6K 0.03% 451
2022
Q3
$232K Buy
1,264
+24
+2% +$4.78K 0.02% 484
2022
Q2
$208K Hold
1,240
0.02% 423
2022
Q1
$311K Hold
1,240
0.03% 369
2021
Q4
$315K Hold
1,240
0.03% 375
2021
Q3
$301K Hold
1,240
0.03% 327
2021
Q2
$236K Buy
+1,240
New +$253K 0.03% 304

Other funds holding HCA

Arete Wealth Advisors's HCA Position: Q3 2023 in Review

Arete Wealth Advisors sold out of HCA Healthcare (HCA) in Q3 2023, closing a stake of 811 shares — an estimated $246K sold.

Arete Wealth Advisors first reported a position in HCA in Q2 2021 and held it in 9 quarters. The position peaked at $498K in Q1 2023. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

  • Arete Wealth Advisors reported no remaining HCA Healthcare position as of Q3 2023 after selling out during the quarter.
  • Arete Wealth Advisors sold 811 HCA Healthcare shares in Q3 2023, an estimated $246K.
  • Arete Wealth Advisors first reported a position in HCA Healthcare in Q2 2021 and held it in 9 quarters.
  • Arete Wealth Advisors's HCA Healthcare position peaked at $498K in Q1 2023.
  • 1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Arete Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.